2026-2030年全球寡核苷酸合成市場

全球寡核苷酸合成市場預計在 2025 年至 2030 年間將成長 55.936 億美元，預測期內複合年成長率為 17.8%。

本報告對全球寡核苷酸合成市場進行了全面分析，包括市場規模和預測、趨勢、成長要素和挑戰，以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。市場成長的促進因素包括寡核苷酸合成方法的技術進步、對基於寡核苷酸的療法的需求不斷成長以及投資和策略合作的激增。

本研究採用客觀的方法，結合一手和二手訊息，包括來自主要行業相關人員的意見。報告包含全面的市場規模數據、區域細分分析、供應商格局以及對主要企業的分析。報告提供歷史數據和預測數據。

研究強調，向酶合成和永續合成方法的轉變是未來幾年推動全球寡核苷酸合成市場成長的主要因素之一。寡核苷酸在治療和精準醫療領域應用範圍的不斷擴大，以及高通量和自動化合成平台的日益普及，預計將顯著提升市場需求。

目錄

第1章執行摘要

第2章 Technavio 分析

• 價格、生命週期、顧客購買籃、採用率和購買標準分析
• 投入與差異化因素的重要性
• 混淆來源
• 促進因素和挑戰的影響

第3章 市場情勢

• 市場生態系統
• 市場特徵
• 價值鏈分析

第4章 市場規模

• 市場定義
• 市場區隔分析
• 2025年市場規模
• 2025-2030年市場展望

第5章 市場規模表現

• 2020-2024年全球寡核苷酸合成市場
• 應用細分市場分析 2020-2024
• 2020-2024年最終用戶細分市場分析
• 2020-2024年產品細分市場分析
• 2020-2024年區域市場分析
• 2020-2024年國家細分市場分析

第6章 定性分析

• 人工智慧的影響：寡核苷酸合成的全球市場

第7章五力分析

• 五力分析概述
• 買方的議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第8章 按應用進行市場細分

• 比較：按應用
• PCR引子
• PCR檢測與試劑盒
• DNA微陣列
• 螢光原位雜合反應
• 其他
• 按應用分類的市場機會

9. 按最終用戶進行市場區隔

• 比較：按最終用戶
• 製藥和生物技術公司
• 研究和學術機構
• 診斷檢查室
• 醫院
• 按最終用戶分類的市場機會

第10章 按產品進行市場細分

• 比較：按產品
• 寡核苷酸產品
• 試劑和耗材
• 合成器
• 按產品分類的市場機會

第11章 客戶情況

第12章 區域情勢

• 區域細分
• 區域比較
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞洲
  • 中國
  • 印度
  • 日本
  • 韓國
  • 泰國
  • 印尼
• 世界其他地區
  • 巴西
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 以色列
  • 南非
  • 土耳其
  • 阿根廷
  • 哥倫比亞
• 各區域的市場機遇

第13章：促進因素、挑戰與機遇

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場機遇

第14章 競爭格局

• 概述
• 競爭格局
• 令人困惑的局面
• 產業風險

第15章 競爭分析

• 公司簡介
• 企業排名指數
• 公司市場定位
• Agilent Technologies Inc.
• Ajinomoto Bio Pharma Services
• Ansa Biotechnologies
• Azenta Inc.
• Bio Synthesis Inc
• Biogen Inc.
• Biotage AB
• Danaher Corp.
• GenScript Biotech Corp.
• Kaneka Corp.
• Merck KGaA
• Nitto Denko Corp.
• QIAGEN NV
• Synbio Technologies LLC
• Thermo Fisher Scientific Inc.

第16章附錄

The global oligonucleotide synthesis market is forecasted to grow by USD 5593.6 mn during 2025-2030, accelerating at a CAGR of 17.8% during the forecast period. The report on the global oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in oligonucleotide synthesis methods, escalating demand for oligonucleotide-based therapeutics, surging investments and strategic collaborations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global oligonucleotide synthesis market is segmented as below:

By Application

• PCR primers
• PCR assays and panels
• DNA microarrays
• Fluorescence in situ hybridization
• Others

By End-User

• Pharmaceutical and biotechnology companies
• Research and academic institutes
• Diagnostic laboratories
• Hospitals

By Product

• Oligonucleotide products
• Reagents and consumables
• Synthesis equipment

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward enzymatic and sustainable synthesis methods as one of the prime reasons driving the global oligonucleotide synthesis market growth during the next few years. Also, expansion of oligonucleotide applications in therapeutics and precision medicine and increasing adoption of high-throughput and automated synthesis platforms will lead to sizable demand in the market.

The report on the global oligonucleotide synthesis market covers the following areas:

• Global oligonucleotide synthesis market sizing
• Global oligonucleotide synthesis market forecast
• Global oligonucleotide synthesis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Bio Pharma Services, Ansa Biotechnologies, Azenta Inc., Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., GenScript Biotech Corp., Kaneka Corp., LGC Ltd., Merck KGaA, Nitto Denko Corp., QIAGEN N.V., Synbio Technologies LLC, Syngene International Ltd., Thermo Fisher Scientific Inc., Twist Bioscience Corp., WuXi AppTec Co. Ltd.. Also, the global oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Oligonucleotide Synthesis Market 2020 - 2024
  • Historic Market Size - Data Table on Global Oligonucleotide Synthesis Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Oligonucleotide Synthesis Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 PCR primers - Market size and forecast 2025-2030
• 8.4 PCR assays and panels - Market size and forecast 2025-2030
• 8.5 DNA microarrays - Market size and forecast 2025-2030
• 8.6 Fluorescence in situ hybridization - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
• 9.4 Research and academic institutes - Market size and forecast 2025-2030
• 9.5 Diagnostic laboratories - Market size and forecast 2025-2030
• 9.6 Hospitals - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Oligonucleotide products - Market size and forecast 2025-2030
• 10.4 Reagents and consumables - Market size and forecast 2025-2030
• 10.5 Synthesis equipment - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
  • 12.6.7 Argentina - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Technological advancements in oligonucleotide synthesis methods
  • Escalating demand for oligonucleotide-based therapeutics
  • Surging investments and strategic collaborations
• 13.2 Market challenges
  • High manufacturing costs and scalability limitations
  • Stringent regulatory requirements and compliance hurdles
  • Complexities in large-scale production and supply chain vulnerabilities
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward enzymatic and sustainable synthesis methods
  • Expansion of oligonucleotide applications in therapeutics and precision medicine
  • Increasing adoption of high-throughput and automated synthesis platforms

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Ajinomoto Bio Pharma Services
  • Ajinomoto Bio Pharma Services - Overview
  • Ajinomoto Bio Pharma Services - Product / Service
  • Ajinomoto Bio Pharma Services - Key offerings
  • SWOT
• 15.6 Ansa Biotechnologies
  • Ansa Biotechnologies - Overview
  • Ansa Biotechnologies - Product / Service
  • Ansa Biotechnologies - Key offerings
  • SWOT
• 15.7 Azenta Inc.
  • Azenta Inc. - Overview
  • Azenta Inc. - Business segments
  • Azenta Inc. - Key news
  • Azenta Inc. - Key offerings
  • Azenta Inc. - Segment focus
  • SWOT
• 15.8 Bio Synthesis Inc
  • Bio Synthesis Inc - Overview
  • Bio Synthesis Inc - Product / Service
  • Bio Synthesis Inc - Key offerings
  • SWOT
• 15.9 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key offerings
  • SWOT
• 15.10 Biotage AB
  • Biotage AB - Overview
  • Biotage AB - Product / Service
  • Biotage AB - Key offerings
  • SWOT
• 15.11 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.12 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.13 Kaneka Corp.
  • Kaneka Corp. - Overview
  • Kaneka Corp. - Business segments
  • Kaneka Corp. - Key news
  • Kaneka Corp. - Key offerings
  • Kaneka Corp. - Segment focus
  • SWOT
• 15.14 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.15 Nitto Denko Corp.
  • Nitto Denko Corp. - Overview
  • Nitto Denko Corp. - Business segments
  • Nitto Denko Corp. - Key offerings
  • Nitto Denko Corp. - Segment focus
  • SWOT
• 15.16 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key news
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.17 Synbio Technologies LLC
  • Synbio Technologies LLC - Overview
  • Synbio Technologies LLC - Product / Service
  • Synbio Technologies LLC - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations